First Nucleic Acid Therapeutics Regional Meeting - India 2025

Supported by a Regional Delivery Grant from the
Oligonucleotide Therapeutics Society
Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)
Bengaluru, February 18th - 21st, 2025
Oligonucleotide Therapeutics Society

(www.oligotherapeutics.org)

The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a forum for the realization of the Society's mission and goals, to foster academic and industry-based research for the development of oligonucleotide therapeutics.

Conference Chairs

Muthaiah Manoharan

(Alnylam, Boston)

Krishna Ganesh

(JNCASR, Bengaluru)

Scientific Advisory Committee

speak

David Corey

(UT Southwatern Medical Cente, USA)

speak

Masad Damha

(McGill University, Canada)

speak

Shalini Anderson

(Astrazeneca, USA)

speak

Aurélie Goyenvalle

(University of Versailles, INSERM, France)

speak

Maja Jonas

(Alnylam Pharmaceuticals)

speak

Fritz Eckstein

(Max-Planck-Institute for Multidisciplinary Sciences, Germany)

speak

Mike Gait

(Medical Research Council, UK)

speak

Sudhir Agarwal

(ARNAY Sciences, USA)

speak

S. Ganesh

(Anthem, India)

speak

Richard Geary

(Ionis Pharmaceuticals, USA)

Conference Grant Supporters

National Advisory Committee

speak

T.Govindaraju

(JNCASR, India)

speak

Jayanta Haldar

(JNCASR, India)

speak

S. G. Srivatsan

(IISER Pune, India)

speak

Vipul Rana

(Innovassynth, India)

speak

Surjit Sinha

(IACS Kolkata, India)

speak

P I Pradeepkumar

(IIT Bombay, India)

speak

K. Kaliappan

(IIT Mumbai)

speak

N. Jayaraman

(IISC Bengaluru)

speak

Moneesha Fernandes

(NCL Pune)

speak

Ashwani Sharma

(IISER Tirupati)

speak

Yella Reddy

(Saphala, Hyderabad)